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Diversity of Bipolaris Species in Clinical Samples in the United States
and Their Antifungal Susceptibility Profiles
K. C. da Cunha,a D. A. Sutton,b A. W. Fothergill,b J. Cano,a J. Gené,a H. Madrid,c S. De Hoog,c P. W. Crous,c and J. Guarroa
Mycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, Reus, Spaina; Fungus Testing Laboratory, University of Texas Health Science Center, San Antonio,
Texas, USAb; and CBS-KNAW Fungal Biodiversity Centre, Utrecht, the Netherlandsc
A set of 104 isolates from human clinical samples from the United States, morphologically compatible with Bipolaris, were mor-
phologically andmolecularly identified through the sequence analysis of the internal transcribed space (ITS) region of the nu-
clear ribosomal DNA (rDNA). The predominant species was Bipolaris spicifera (67.3%), followed by B. hawaiiensis (18.2%), B.
cynodontis (8.6%), B. micropus (2.9%), B. australiensis (2%), and B. setariae (1%). Bipolaris cynodontis, B. micropus, and B.
setariae represent new records from clinical samples. The most common anatomical sites where isolates were recovered were the
nasal region (30.7%), skin (19.2%), lungs (14.4%), and eyes (12.5%). The antifungal susceptibilities of 5 species of Bipolaris to 9
drugs are provided. With the exception of fluconazole and flucytosine, the antifungals tested showed good activity.
Bipolaris is a large genus of dematiaceous hyphomycetes withmore than 100 species, most of them being saprobes in soil
and pathogens of plants, while some of the saprobic species are
potentially able to infect humans and animals (27). They are ana-
morphs of the ascomycetous genera Cochliobolus and Pseudoco-
chliobolus (family Pleosporaceae, order Pleosporales) (20).
The typical morphological features of Bipolaris species include
rapidly growing dark colonies, geniculate conidiophores with
sympodial conidiogenesis, and large conidia with transverse dis-
tosepta, usually without a protuberant hilum (a basal scar indicat-
ing the point of attachment in the conidiogenous cell) and with
bipolar germination.Morphologically similar anamorphic genera
are Drechslera, Curvularia, and Exserohilum (27).
Clinically relevant Bipolaris species are B. australiensis, B.
hawaiiensis, B. spicifera, and, to a lesser extent, B. papendorfii
(8). These fungi are able to infect both immunocompetent and
immunosuppressed patients, mainly in tropical and subtropi-
cal areas. The most common clinical presentations are allergic
sinusitis, keratitis, endophthalmitis, onychomycosis, perito-
neal dialysis-associated peritonitis, lung and skin infections,
and, less frequently, central nervous system (CNS) infections
(2, 4, 5, 10, 16, 26, 28, 31).
The prevalence of the different species of Bipolaris in human
infections is poorly known since only a few studies involving this
genus have been published and the isolates were usually identified
only by morphological criteria. Considering the similarity among
the species of Bipolaris and the fact that the separation of species is
based on subtle characters, some published identifications are
doubtful or remain unresolved (10, 26). In the present study, we
have identified a large number of isolates of clinical origin by
molecular methods and by comparison of their sequences with
those of type or reference strains in order to assess the spectrum of
Bipolaris species in clinical samples in the United States.
MATERIALS AND METHODS
Fungal isolates. A total of 104 isolates from human clinical samples, pre-
sumably belonging to the genus Bipolaris, were morphologically exam-
ined and sequenced in the present study (see the supplemental material).
They were received at the Fungus Testing Laboratory in the Department
of Pathology at the University of Texas Health Science Center at San
Antonio, mostly over a period of 5 years (2006 to 2010), for identification
or antifungal susceptibility determination. In addition, 14 ex-type or ref-
erence strains were also included in the study.
Morphological study.All isolates were cultured on potato carrot agar
(PCA; 20 g of potatoes, 20 g of carrots, 20 g of agar, 1 liter of distilled
water) and oatmeal agar (OA; 30 g of filtered oat flakes, 20 g of agar, 1 liter
of distilled water) media and incubated at 25°C for 10 to 21 days. The
identification criteria were after Ellis (11, 12) and Sivanesan (27). Using
light microscopy, microscopic features were examined by making direct
wet mounts in 85% lactic acid from the different culture media.
Molecular study. Isolates were grown on yeast extract sucrose (YES;
yeast extract, 2%; sucrose, 15%; agar, 2%; water, 1 liter) for 3 days at 25°C,
and DNA was extracted using a PrepMan Ultra sample preparation re-
agent (Applied Biosystems, Foster City, CA) according to the manufac-
turer’s protocol. Briefly, the fungal mycelium from a colony was gently
mixed with 100l of the PrepMan Ultra sample reagent (Applied Biosys-
tems, Foster City, CA). The mixture was then incubated at 100°C for 10
min, pelleted by centrifugation for 8min at 13,000 rpm, and stored at 4°C.
The DNA was quantified using GeneQuant pro (Amersham Pharmacia
Biotech, Cambridge, England). The internal transcribed spacer (ITS) re-
gion of the nuclear ribosomal DNA (rDNA) was amplified and sequenced
following the protocol described by Álvarez et al. (1). The specific primers
used for the amplification of the ITS region were ITS 5, 5= GGAAGTAAA
AGTCGTAACAAGG 3=, and ITS 4, 5= TCCTCCGCTTATTGATATGC
3=, and the expected size of the PCR products was 575 bp.
The program SeqMan (Lasergene, Madison, Wisconsin) was used to
obtain consensus sequences from the complementary sequences of each
isolate.
Phylogenetic analysis. Nucleotide sequence alignments were per-
formed with Clustal X version 1.81 (30), followed bymanual adjustments
with a text editor. Distance trees were constructed with the maximum
likelihood (ML) method using the Kimura 2-parameter substitution
model with a pairwise deletion of gaps, as implemented in the MEGA 5.0
computer program (29). The robustness of branches was assessed by a
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bootstrap analysis of 1,000 replicates. The sequences ofCorynespora cassii-
cola (IMI 056007, U95173.1) and Alternaria alternata (CBS 916.96,
FJ196306) were used as outgroups in the ITS analysis.
Antifungal susceptibility.A total of 77 isolateswith sufficient conidial
production to standardize an inoculum were tested. Antifungal suscepti-
bility testing was accomplished via methods outlined in CLSI document
M38-A2 (7). This involves standardizing the inoculum by spectropho-
tometer to 0.4 104 to 5 104 CFU/ml (0.25 to 0.3 optical density at 530
nm [OD530]), use of RPMI 1640 with L-glutamine but without bicarbon-
ate, and incubation at 35°C. The minimum effective concentration
(MEC) was determined at 24 h for the candins, and the MIC was deter-
mined at 48 h for the remaining drugs. TheMICwas defined as the lowest
concentration exhibiting 100% visual inhibition of growth for amphoter-
icin B, itraconazole, posaconazole, and voriconazole while at a 50% re-
duction in growth for fluconazole and flucytosine. In the event that suf-
ficient growth was not observed at the prescribed reading times, the tests
continued to be incubated until sufficient growth was observed, enabling
accurate endpoint determination.
RESULTS
Of the 104 clinical isolates studied, 100 were morphologically
identified as members of the genus Bipolaris. Four isolates did not
sporulate (UTHSC 07-3454, UTHSC 08-1495, UTHSC 10-2300,
and UTHSC 10-2807), but the analysis of their ITS sequences
demonstrated that they were B. spicifera.
With the primers used, wewere able to amplify and sequence 571
to 575 bp of the ITS region. The predominant species was Bipolaris
spicifera (70 isolates, 67.3%), followed by B. hawaiiensis (19 isolates,
18.2%), B. cynodontis (9 isolates, 8.6%), B. micropus (3 isolates,
2.9%),B. australiensis (2 isolates, 2%), andB. setariae (1 isolate, 1%).
The correlation between the morphological and molecular identifi-
cation was 89.7%.
In addition to the 14 reference and ex-type strains, 70 of 104
clinical isolates were included in the phylogenetic analysis. Of the
70 isolates identified as B. spicifera, 36 were randomly chosen for
the analysis since the sequences of the isolates of the mentioned
species were very similar (99.4 to 100% similarity). Figure 1 shows
the neighbor-joining (NJ) tree inferred from the analysis of the
ITS region of a representative number of isolates treated in this
study, including the type and reference strains. The isolates from
clinical origin that were included in the analysis clustered in six
well-supported clades, each of them representing a different phy-
logenetic species. The largest clade, comprising the ex-type strain
of B. spicifera and 36 clinical isolates, received 88% of bootstrap
support (BS). The sequences of the isolates of this clade deviated
maximally by 0.6% from that of the ex-type strain of B. spicifera
(MUCL 3017). Isolates were characterized by brown, gray, or
black colonies and 3-distoseptate cylindrical conidia with
rounded ends, measuring 13 to 41 by 7 to 14 m, without a pro-
tuberant hilum that were medium brown, except for a narrow
hyaline to subhyaline area just above the conidial scar (Fig. 2A).
The ex-type strain of B. australiensis and two clinical isolates,
morphologically identified as this species, constituted another
clade (BS, 77%). The similarity of the sequences of such isolates
with the ex-type strain was 98.1%. They showed gray to blackish
brown, velvety colonies and pale brown to medium reddish
brown, 3-distoseptate, ellipsoidal or oblong, straight conidia with
rounded ends, measuring 15 to 32 by 7 to 11 m, with a nonpro-
tuberant hilum and smooth to finely roughened walls (Fig. 2B).
The clade corresponding to B. hawaiiensis (BS, 64%) encom-
passed 19 clinical isolates in addition to the ex-type strain with
which it showed 99.1 to 100% similarity. The species was charac-
terized by pale to medium brown, 2- to 6-distoseptate, oblong,
cylindrical, or ellipsoidal conidia, measuring 13 to 37 by 4 to 11
m, with a nonprotuberant hilum (Fig. 2C).
Three reference strains of B. micropuswere grouped with three
clinical isolates that had been morphologically identified as this
species (BS, 96%). These isolates produced conidia that were pale
brown, 3- to 7-distoseptate, cylindrical, and straight, measuring
19 to 47 by 10 to 15 m, with smooth walls and a short protuber-
ant hilum (Fig. 2D).
Isolate UTHSC 05-3211 showed 99% similarity with a refer-
ence strain of B. setariae (CBS 141.31). The clinical isolate showed
pale brown, 3- to 9-distoseptate conidia that were cylindrical and
straight to slightly curved,measuring 37 to 92 by 11 to 16m,with
a nonprotuberant hilum (Fig. 2E). These conidial features were
similar to those described forB. sacchari andB. setariae (30).How-
ever, no type strains of those species are known to exist and, in
addition, our isolate only showed a similarity of 95.5% with a
reference strain of B. sacchari (CBS 324.64).
Nine clinical isolates were grouped with four reference strains
of B. cynodontis (BS, 97%). The sequence similarity among the
isolates of this clade was 99.4 to 100%. However, important mor-
phological differences were observed among them. Most showed
conidial features typical of B. cynodontis; i.e., conidia with 3 to 8
distosepta, narrowly ellipsoidal to oval, irregularly curved, with-
out a protuberant hilum, pale brown, and smooth-walled, mea-
suring 19 to 61 by 8 to 15 m (Fig. 2E). In contrast, two isolates
(UTHSC 07-557 and UTHSC 07-3862) showed considerably
shorter (up to 41-m-long) conidiawith fewer septa (from3 to 6).
The majority of the isolates included in this study were from
the nasal region (30.7%), followed by various cutaneous presen-
tations (19.2%) and the lungs (14.4%), eyes (12.5%), nails (7.6%),
and blood (4.8%). The remaining 10.8% of the isolates were from
other sites like the ear, the brain, bile, and the chest, among others.
With the exception of fluconazole and flucytosine, the antifun-
gal drugs tested showed good activity against all the isolates tested
(Table 1). The MICs of the three drugs most commonly tested in
these types of infections, i.e., amphotericin B, voriconazole, and
itraconazole, were 0.03 to 2, 0.05 to 2, and 0.03 to 4 g/ml,
respectively.
DISCUSSION
This is the first study where a large panel of clinical isolates of
Bipolaris has been identified down to the species level using both
phenotypic and molecular methods. Although it seems that Bipo-
laris is an uncommon fungus involved in human infections, the
fact that more than 250 clinical isolates belonging to that genus
were received at the Fungus Testing Laboratory over a period of 5
years demonstrates that its low incidence is only relative. Close to
100 of such isolates were included in the present study. However,
it should be mentioned that the role of these isolates as a cause of
infection was not demonstrated.
A recent retrospective study, performed in Saudi Arabia (10),
recorded a total of 23 clinical isolates of Bipolaris from different
anatomical sites, collected over a period of 2 years. Although they
were identified only morphologically, the most frequent species
were B. spicifera, B. australiensis, and B. hawaiiensis, a finding
which, in general, correlates with the prevalent etiologic agents in
human infections reported in the literature (5, 15, 17, 19, 21, 23).
In our study, B. spicifera and B. hawaiiensis were also the most
da Cunha et al.
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FIG 1 Maximum likelihood tree inferred from ITS sequences of Bipolaris listed in Table S1 in the supplemental material. Branch lengths are proportional to the
distance. Type or reference strains are shown in bold.
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commonly identified species, but, surprisingly,B. australiensiswas
represented only by two isolates. The fact that B. spicifera and B.
australiensis are morphologically similar, especially when they
grow in vitro, may have been a cause of misidentification in many
cases. Bipolaris spicifera differs from B. australiensis by its 3-disto-
septate conidia, which show a pale area at the base, just above the
scar, while those of B. australiensis are usually 3- to 4(5)-disto-
septate, and the pale basal area is absent (27). The ITS sequences of
the type strains of both species showed a similarity of 97.8%. Bi-
polaris hawaiiensis is morphologically distinguished from B. spic-
ifera and B. australiensis by its 5(7)-distoseptate narrow conidia
(up to 7 m wide), while those of B. australiensis and B. spicifera
are 6 to 11 m and 9 to 14 m wide, respectively (27). The ITS
sequence of the type strain of B. hawaiiensis showed similarities of
93.7 and 94.8%with those of the type strains ofB. australiensis and
B. spicifera, respectively. A BLAST search comparing ITS se-
quences is the procedure usually used in recent years to confirm
Bipolaris species identification (3, 6, 9, 16, 18). However, this pro-
cedure may not be useful when comparisons are made with inac-
curate sequences or when sequences of authentic strains of the
species to which the problem isolate belongs have not been depos-
ited.
Interestingly, we identified three species, B. cynodontis, B. mi-
cropus, and B. setariae, which, up to now, never had been found in
clinical samples. In contrast, Bipolaris papendorfii, reported in
three clinical cases (8), was not found in this study.
In our study, the predominant anatomic sites where strains
were isolated were the nasal region, the eye, and the skin, a finding
which agrees with the clinical cases ofBipolaris infections reported
in the literature (5, 10, 15, 17, 19, 21, 23, 26).
The remarkably high in vitro activity of most of the antifungal
drugs tested against Bipolaris species agrees with previous studies
FIG 2 Conidia ofBipolaris species onOA at 25°C after 10 days. (A)B. spicifera, UTHSC 08-1706; (B)B. australiensis, UTHSC 09-406; (C)B. hawaiiensis, UTHSC
09-2906; (D) B. micropus, UTHSC 06-3896; (E) B. setariae, UTHSC05-3211; and (F) B. cynodontis, UTHSC 09-507. Scale bars, 10 m.
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(13, 14, 24, 25). Owing to the infrequent occurrence of Bipolaris
infections, clinical experience on their treatment is very scarce. In
the reported clinical case studies, different antifungal drugs, such
as amphotericin B, itraconazole, and voriconazole, have been
used, with variable results (6, 15, 17, 22, 26, 31).
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